1143 related articles for article (PubMed ID: 25149123)
61. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
62. Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo.
Dong Y; Fu R; Yang J; Ma P; Liang L; Mi Y; Fan D
Int J Nanomedicine; 2019; 14():6971-6988. PubMed ID: 31507319
[TBL] [Abstract][Full Text] [Related]
63. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
64. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.
Zhang Y; Li J; Lang M; Tang X; Li L; Shen X
J Colloid Interface Sci; 2011 Feb; 354(1):202-9. PubMed ID: 21094493
[TBL] [Abstract][Full Text] [Related]
65. Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles.
Zhang LK; Hou SX; Zhang JQ; Hu WJ; Wang CY
Arch Pharm Res; 2010 Aug; 33(8):1193-8. PubMed ID: 20803122
[TBL] [Abstract][Full Text] [Related]
66. Targeted gene delivery by new folate-polycationic amphiphilic cyclodextrin-DNA nanocomplexes in vitro and in vivo.
Aranda C; Urbiola K; Méndez Ardoy A; García Fernández JM; Ortiz Mellet C; de Ilarduya CT
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):390-7. PubMed ID: 23811437
[TBL] [Abstract][Full Text] [Related]
67. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
[TBL] [Abstract][Full Text] [Related]
68. Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.
Yin JJ; Sharma S; Shumyak SP; Wang ZX; Zhou ZW; Zhang Y; Guo P; Li CZ; Kanwar JR; Yang T; Mohapatra SS; Liu W; Duan W; Wang JC; Li Q; Zhang X; Tan J; Jia L; Liang J; Wei MQ; Li X; Zhou SF
PLoS One; 2013; 8(5):e62289. PubMed ID: 23658721
[TBL] [Abstract][Full Text] [Related]
69. Quantitative control of active targeting of nanocarriers to tumor cells through optimization of folate ligand density.
Tang Z; Li D; Sun H; Guo X; Chen Y; Zhou S
Biomaterials; 2014 Sep; 35(27):8015-27. PubMed ID: 24947231
[TBL] [Abstract][Full Text] [Related]
70. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
Zhang G; Liu F; Jia E; Jia L; Zhang Y
Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
[TBL] [Abstract][Full Text] [Related]
71. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
Wu G; Wang Z; Bian X; Du X; Wei C
Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652
[TBL] [Abstract][Full Text] [Related]
72. Targeted Nanoparticles for Fluorescence Imaging of Folate Receptor Positive Tumors.
Marko AJ; Borah BM; Siters KE; Missert JR; Gupta A; Pera P; Isaac-Lam MF; Pandey RK
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33317162
[TBL] [Abstract][Full Text] [Related]
73. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
[TBL] [Abstract][Full Text] [Related]
74. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
Wang WY; Cao YX; Zhou X; Wei B
Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
[No Abstract] [Full Text] [Related]
75. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier].
Gong JL; Wang SM; Hu XG; Cao MM; Zhang JR
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2183-6. PubMed ID: 19114352
[TBL] [Abstract][Full Text] [Related]
76. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
[TBL] [Abstract][Full Text] [Related]
77. Targeting tumor cells through chitosan-folate modified microcapsules loaded with camptothecin.
Galbiati A; Tabolacci C; Morozzo Della Rocca B; Mattioli P; Beninati S; Paradossi G; Desideri A
Bioconjug Chem; 2011 Jun; 22(6):1066-72. PubMed ID: 21545180
[TBL] [Abstract][Full Text] [Related]
78. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin.
Kameyama K; Motoyama K; Tanaka N; Yamashita Y; Higashi T; Arima H
Int J Nanomedicine; 2017; 12():3433-3446. PubMed ID: 28496320
[TBL] [Abstract][Full Text] [Related]
79. Synthesis and evaluation of folate-based chlorambucil delivery systems for tumor-targeted chemotherapy.
Guaragna A; Chiaviello A; Paolella C; D'Alonzo D; Palumbo G; Palumbo G
Bioconjug Chem; 2012 Jan; 23(1):84-96. PubMed ID: 22121907
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of antitumor effects of folate-conjugated methyl-β-cyclodextrin in melanoma.
Motoyama K; Onodera R; Tanaka N; Kameyama K; Higashi T; Kariya R; Okada S; Arima H
Biol Pharm Bull; 2015; 38(3):374-9. PubMed ID: 25757918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
